この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 2010/9/101 分で読めます
Schmid Laboratories, Inc. et al.; Withdrawal of Approval of Five New Drug Applications
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is withdrawing approval of five new drug applications (NDAs) from multiple holders of these applications. The basis for the withdrawals is that the holders of the applications have repeatedly failed to file required annual reports for the applications.
情報源の原言語: Federal Register — Health and Human Services原文の発表を開く →